Thioredoxin reductase 1 regulates hepatic inflammation and macrophage activation during acute cholestatic liver injury
Background and Aims:. Cholestatic liver diseases, including primary sclerosing cholangitis, are characterized by periportal inflammation with progression to hepatic fibrosis and ultimately cirrhosis. We recently reported that the thioredoxin antioxidant response is dysregulated during primary sclero...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Health/LWW
2023-01-01
|
| Series: | Hepatology Communications |
| Online Access: | http://journals.lww.com/10.1097/HC9.0000000000000020 |
| _version_ | 1828000630639165440 |
|---|---|
| author | Colin T. Shearn Aimee L. Anderson Colin G. Miller Reed C. Noyd Michael W. Devereaux Nata Balasubramaniyan David J. Orlicky Edward E. Schmidt Ronald J. Sokol |
| author_facet | Colin T. Shearn Aimee L. Anderson Colin G. Miller Reed C. Noyd Michael W. Devereaux Nata Balasubramaniyan David J. Orlicky Edward E. Schmidt Ronald J. Sokol |
| author_sort | Colin T. Shearn |
| collection | DOAJ |
| description | Background and Aims:. Cholestatic liver diseases, including primary sclerosing cholangitis, are characterized by periportal inflammation with progression to hepatic fibrosis and ultimately cirrhosis. We recently reported that the thioredoxin antioxidant response is dysregulated during primary sclerosing cholangitis. The objective of this study was to examine the impact of genetic and pharmacological targeting of thioredoxin reductase 1 (TrxR1) on hepatic inflammation and liver injury during acute cholestatic injury.
Approach and Results:. Primary mouse hepatocytes and intrahepatic macrophages were isolated from 3-day bile duct ligated (BDL) mice and controls. Using wildtype and mice with a liver-specific deletion of TrxR1 (TrxR1LKO), we analyzed the effect of inhibition or ablation of TrxR1 signaling on liver injury and inflammation. Immunohistochemical analysis of livers from BDL mice and human cholestatic patients revealed increased TrxR1 staining in periportal macrophages and hepatocytes surrounding fibrosis. qPCR analysis of primary hepatocytes and intrahepatic macrophages revealed increased TrxR1 mRNA expression following BDL. Compared with sham controls, BDL mice exhibited increased inflammation, necrosis, and increased mRNA expression of pro-inflammatory cytokines, fibrogenesis, the NLRP3 inflammatory complex, and increased activation of NFkB, all of which were ameliorated in TrxR1LKO mice. Importantly, following BDL, TrxR1LKO induced periportal hepatocyte expression of Nrf2-dependent antioxidant proteins and increased mRNA expression of basolateral bile acid transporters with reduced expression of bile acid synthesis genes. In the acute BDL model, the TrxR1 inhibitor auranofin (10 mg/kg/1 d preincubation, 3 d BDL) ameliorated BDL-dependent increases in Nlrp3, GsdmD, Il1β, and TNFα mRNA expression despite increasing serum alanine aminotransferase, aspartate aminotransferase, bile acids, and bilirubin.
Conclusions:. These data implicate TrxR1-signaling as an important regulator of inflammation and bile acid homeostasis in cholestatic liver injury. |
| first_indexed | 2024-04-10T06:17:19Z |
| format | Article |
| id | doaj.art-65bdde1608a44f779026293984db4f20 |
| institution | Directory Open Access Journal |
| issn | 2471-254X |
| language | English |
| last_indexed | 2024-04-10T06:17:19Z |
| publishDate | 2023-01-01 |
| publisher | Wolters Kluwer Health/LWW |
| record_format | Article |
| series | Hepatology Communications |
| spelling | doaj.art-65bdde1608a44f779026293984db4f202023-03-02T06:29:29ZengWolters Kluwer Health/LWWHepatology Communications2471-254X2023-01-0171e0020e002010.1097/HC9.0000000000000020HC90000000000000020Thioredoxin reductase 1 regulates hepatic inflammation and macrophage activation during acute cholestatic liver injuryColin T. Shearn0Aimee L. Anderson1Colin G. Miller2Reed C. Noyd3Michael W. Devereaux4Nata Balasubramaniyan5David J. Orlicky6Edward E. Schmidt7Ronald J. Sokol8 1 Department of Pediatrics, Section of Pediatric Gastroenterology, Hepatology and Nutrition, University of Colorado School of Medicine, Aurora, Colorado, USA 1 Department of Pediatrics, Section of Pediatric Gastroenterology, Hepatology and Nutrition, University of Colorado School of Medicine, Aurora, Colorado, USA 4 Department of Microbiology & Cell Biology, Montana State University, Bozeman, Montana, USA 4 Department of Microbiology & Cell Biology, Montana State University, Bozeman, Montana, USA 1 Department of Pediatrics, Section of Pediatric Gastroenterology, Hepatology and Nutrition, University of Colorado School of Medicine, Aurora, Colorado, USA 1 Department of Pediatrics, Section of Pediatric Gastroenterology, Hepatology and Nutrition, University of Colorado School of Medicine, Aurora, Colorado, USA 3 Department of Pathology, University of Colorado School of Medicine, Aurora, Colorado, USA 4 Department of Microbiology & Cell Biology, Montana State University, Bozeman, Montana, USA 1 Department of Pediatrics, Section of Pediatric Gastroenterology, Hepatology and Nutrition, University of Colorado School of Medicine, Aurora, Colorado, USABackground and Aims:. Cholestatic liver diseases, including primary sclerosing cholangitis, are characterized by periportal inflammation with progression to hepatic fibrosis and ultimately cirrhosis. We recently reported that the thioredoxin antioxidant response is dysregulated during primary sclerosing cholangitis. The objective of this study was to examine the impact of genetic and pharmacological targeting of thioredoxin reductase 1 (TrxR1) on hepatic inflammation and liver injury during acute cholestatic injury. Approach and Results:. Primary mouse hepatocytes and intrahepatic macrophages were isolated from 3-day bile duct ligated (BDL) mice and controls. Using wildtype and mice with a liver-specific deletion of TrxR1 (TrxR1LKO), we analyzed the effect of inhibition or ablation of TrxR1 signaling on liver injury and inflammation. Immunohistochemical analysis of livers from BDL mice and human cholestatic patients revealed increased TrxR1 staining in periportal macrophages and hepatocytes surrounding fibrosis. qPCR analysis of primary hepatocytes and intrahepatic macrophages revealed increased TrxR1 mRNA expression following BDL. Compared with sham controls, BDL mice exhibited increased inflammation, necrosis, and increased mRNA expression of pro-inflammatory cytokines, fibrogenesis, the NLRP3 inflammatory complex, and increased activation of NFkB, all of which were ameliorated in TrxR1LKO mice. Importantly, following BDL, TrxR1LKO induced periportal hepatocyte expression of Nrf2-dependent antioxidant proteins and increased mRNA expression of basolateral bile acid transporters with reduced expression of bile acid synthesis genes. In the acute BDL model, the TrxR1 inhibitor auranofin (10 mg/kg/1 d preincubation, 3 d BDL) ameliorated BDL-dependent increases in Nlrp3, GsdmD, Il1β, and TNFα mRNA expression despite increasing serum alanine aminotransferase, aspartate aminotransferase, bile acids, and bilirubin. Conclusions:. These data implicate TrxR1-signaling as an important regulator of inflammation and bile acid homeostasis in cholestatic liver injury.http://journals.lww.com/10.1097/HC9.0000000000000020 |
| spellingShingle | Colin T. Shearn Aimee L. Anderson Colin G. Miller Reed C. Noyd Michael W. Devereaux Nata Balasubramaniyan David J. Orlicky Edward E. Schmidt Ronald J. Sokol Thioredoxin reductase 1 regulates hepatic inflammation and macrophage activation during acute cholestatic liver injury Hepatology Communications |
| title | Thioredoxin reductase 1 regulates hepatic inflammation and macrophage activation during acute cholestatic liver injury |
| title_full | Thioredoxin reductase 1 regulates hepatic inflammation and macrophage activation during acute cholestatic liver injury |
| title_fullStr | Thioredoxin reductase 1 regulates hepatic inflammation and macrophage activation during acute cholestatic liver injury |
| title_full_unstemmed | Thioredoxin reductase 1 regulates hepatic inflammation and macrophage activation during acute cholestatic liver injury |
| title_short | Thioredoxin reductase 1 regulates hepatic inflammation and macrophage activation during acute cholestatic liver injury |
| title_sort | thioredoxin reductase 1 regulates hepatic inflammation and macrophage activation during acute cholestatic liver injury |
| url | http://journals.lww.com/10.1097/HC9.0000000000000020 |
| work_keys_str_mv | AT colintshearn thioredoxinreductase1regulateshepaticinflammationandmacrophageactivationduringacutecholestaticliverinjury AT aimeelanderson thioredoxinreductase1regulateshepaticinflammationandmacrophageactivationduringacutecholestaticliverinjury AT colingmiller thioredoxinreductase1regulateshepaticinflammationandmacrophageactivationduringacutecholestaticliverinjury AT reedcnoyd thioredoxinreductase1regulateshepaticinflammationandmacrophageactivationduringacutecholestaticliverinjury AT michaelwdevereaux thioredoxinreductase1regulateshepaticinflammationandmacrophageactivationduringacutecholestaticliverinjury AT natabalasubramaniyan thioredoxinreductase1regulateshepaticinflammationandmacrophageactivationduringacutecholestaticliverinjury AT davidjorlicky thioredoxinreductase1regulateshepaticinflammationandmacrophageactivationduringacutecholestaticliverinjury AT edwardeschmidt thioredoxinreductase1regulateshepaticinflammationandmacrophageactivationduringacutecholestaticliverinjury AT ronaldjsokol thioredoxinreductase1regulateshepaticinflammationandmacrophageactivationduringacutecholestaticliverinjury |